These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 294099)

  • 1. Disseminated superficial porokeratosis in patients with pemphigus vulgaris treated with steroids.
    Feuerman EJ; Sandbank M
    Acta Derm Venereol Suppl (Stockh); 1979; 59(85):59-61. PubMed ID: 294099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressants and prednisone in pemphigus vulgaris: therapeutic results obtained in 63 patients between 1961 and 1975.
    Lever WF; Schaumburg-Lever G
    Arch Dermatol; 1977 Sep; 113(9):1236-41. PubMed ID: 900969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated superficial porokeratosis and immunosuppression.
    Neumann RA; Knobler RM; Metze D; Jurecka W
    Br J Dermatol; 1988 Sep; 119(3):375-80. PubMed ID: 2972310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.
    Werth VP
    Arch Dermatol; 1996 Dec; 132(12):1435-9. PubMed ID: 8961871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Post-mortem evaluation in endemic pemphigus foliaceus and pemphigus vulgaris].
    Aki HE; Sotto MN; Sampaio SA
    Med Cutan Ibero Lat Am; 1984; 12(2):151-7. PubMed ID: 6374324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful use of cyclophosphamide and prednisone for initial treatment of pemphigus vulgaris.
    Fellner MJ; Katz JM; McCabe JB
    Arch Dermatol; 1978 Jun; 114(6):889-94. PubMed ID: 666324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of pemphigus vulgaris by azathioprine and low doses of prednisone (Lever scheme)].
    Benoit Corven C; Carvalho P; Prost C; Verret JL; Saiag P; Noblesse I; Bedane C; Chosidow O; Young P; Roujeau JC; Joly P
    Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 1):13-5. PubMed ID: 12605150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of segmental superficial actinic porokeratosis during immunosuppressive therapy for pemphigus vulgaris.
    Buhl T; Wienrich BG; Sieblist C; Schön MP; Seitz CS
    Acta Derm Venereol; 2010 Mar; 90(2):212-3. PubMed ID: 20169319
    [No Abstract]   [Full Text] [Related]  

  • 9. Cell-mediated immunity in patients with less than pemphigus vulgaris greater than before, during and after prolonged treatment with steroids.
    Shohat B; David M; Feuerman EJ
    Biomedicine; 1981 Jul; 35(3):101-3. PubMed ID: 6974011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A clinical analysis of 64 cases of pemphigus].
    He Z; Wang B; Yu B
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Apr; 20(2):144-7. PubMed ID: 11367721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid sparing effect of intravenous immunoglobulin therapy in patients with pemphigus foliaceus.
    Sami N; Qureshi A; Ahmed AR
    Eur J Dermatol; 2002; 12(2):174-8. PubMed ID: 11872417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris.
    Heaphy MR; Albrecht J; Werth VP
    Arch Dermatol; 2005 Jun; 141(6):699-702. PubMed ID: 15967915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
    Mahajan VK; Sharma NL; Sharma RC; Garg G
    Int J Dermatol; 2005 Oct; 44(10):821-7. PubMed ID: 16207182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of pemphigus vulgaris with etanercept in four patients.
    Shetty A; Marcum CB; Glass LF; Carter JD
    J Drugs Dermatol; 2009 Oct; 8(10):940-3. PubMed ID: 19852124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoablative high-dose cyclophosphamide without stem cell rescue in a patient with pemphigus vulgaris.
    Hayag MV; Cohen JA; Kerdel FA
    J Am Acad Dermatol; 2000 Dec; 43(6):1065-9. PubMed ID: 11100024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaposi's sarcoma after steroid therapy for pemphigus foliaceus.
    Qian XC; Huang YZ; Huang RK
    Chin Med J (Engl); 1989 Aug; 102(8):647-9. PubMed ID: 2517623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Successful treatment of corticoid-resistant pemphigus with high-dose intravenous immunoglobulins].
    Sibaud V; Beylot-Barry M; Doutre MS; Beylot C
    Ann Dermatol Venereol; 2000 Apr; 127(4):408-10. PubMed ID: 10844264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pemphigus vulgaris and disseminated coccidioidomycosis.
    Krulig L; Jacobs PH; Loeffel D
    Sabouraudia; 1976 Mar; 14(1):5-9. PubMed ID: 1265574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved protocol for treatment of pemphigus vulgaris with protein A immunoadsorption.
    Shimanovich I; Herzog S; Schmidt E; Opitz A; Klinker E; Bröcker EB; Goebeler M; Zillikens D
    Clin Exp Dermatol; 2006 Nov; 31(6):768-74. PubMed ID: 16824051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pemphigus foliaceus presenting as eruptive seborrheic keratosis and responding to oral gold treatment.
    Bagheri MM; Alagheband M; Memar OM; Eiler DB
    J Drugs Dermatol; 2002 Dec; 1(3):333-4. PubMed ID: 12851996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.